NCT00191711View on ClinicalTrials.gov

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

October 31, 2005

Conditions
Superficial Bladder Cancer
Interventions
DRUG

Gemcitabine

Trial Locations (1)

50019

For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your physician, Sesto Fiorentino

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191711 - Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk. | Biotech Hunter | Biotech Hunter